Cargando…

Characteristics of gut microbiota in patients with metabolic associated fatty liver disease

Metabolic associated fatty liver disease (MAFLD) is rising in incidence and is an increasingly common cause of cirrhosis and hepatocellular carcinoma (HCC). Alterations in the gut microbiota have been shown to correlate with the development and progression of MAFLD. However, little is known regardin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Chao, Xu, Jianguo, Xu, Xiaomin, Xu, Wen, Tong, Bangzhuo, Wang, Shulin, Ji, Rujie, Tan, Yan, Zhu, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281992/ https://www.ncbi.nlm.nih.gov/pubmed/37340081 http://dx.doi.org/10.1038/s41598-023-37163-4

Ejemplares similares

Associations of Gut Microbiota and Fatty Metabolism With Immune Thrombocytopenia
por: Yu, Xiaomin, et al.
Publicado: (2022)

Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Characteristic gut microbiota and metabolic changes in patients with pulmonary tuberculosis
por: Wang, Shuting, et al.
Publicado: (2021)

Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic Diseases
por: Hernández-Ceballos, Winston, et al.
Publicado: (2021)

Characterization of gut dominant microbiota in obese patients with nonalcoholic fatty liver disease
por: Jin, Li-ting, et al.
Publicado: (2023)

Disentangling the Progression of Non-alcoholic Fatty Liver Disease in the Human Gut Microbiota
por: Wang, Tianjiao, et al.
Publicado: (2021)

Gut microbiota therapy for nonalcoholic fatty liver disease: Evidence from randomized clinical trials
por: Han, Ting-Rui, et al.
Publicado: (2023)

Non-alcoholic fatty liver and the gut microbiota
por: Bashiardes, Stavros, et al.
Publicado: (2016)

Hepatic Mitochondria-Gut Microbiota Interactions in Metabolism-Associated Fatty Liver Disease
por: Bellanti, Francesco, et al.
Publicado: (2023)

Gut Microbiota, Glucose, Lipid, and Water-Electrolyte Metabolism in Children With Nonalcoholic Fatty Liver Disease
por: Pan, Xiongfeng, et al.
Publicado: (2021)

Gut Microbiota and Clinical Disease: Obesity and Nonalcoholic Fatty Liver Disease
por: Park, Ji Sook, et al.
Publicado: (2013)

Fu brick tea alleviates high fat induced non-alcoholic fatty liver disease by remodeling the gut microbiota and liver metabolism
por: Tang, Yan, et al.
Publicado: (2022)

The Metabolic Role of Gut Microbiota in the Development of Nonalcoholic Fatty Liver Disease and Cardiovascular Disease
por: Sanduzzi Zamparelli, Marco, et al.
Publicado: (2016)

Structural and Functional Modulation of Gut Microbiota by Jiangzhi Granules during the Amelioration of Nonalcoholic Fatty Liver Disease
por: Wang, Rui-rui, et al.
Publicado: (2021)

Implication of Gut Microbiota in Nonalcoholic Fatty Liver Disease
por: Boursier, Jerome, et al.
Publicado: (2015)

Vitamin C and vitamin D(3) alleviate metabolic-associated fatty liver disease by regulating the gut microbiota and bile acid metabolism via the gut-liver axis
por: Chen, Qingling, et al.
Publicado: (2023)

Mapping the human oral and gut fungal microbiota in patients with metabolic dysfunction-associated fatty liver disease
por: Niu, Chenguang, et al.
Publicado: (2023)

The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease
por: Ni, Yiming, et al.
Publicado: (2022)

Integrative analysis of gut microbiota and fecal metabolites in metabolic associated fatty liver disease patients
por: Yang, Lidan, et al.
Publicado: (2022)

Intragastric Safflower Yellow Alleviates HFD Induced Metabolic Dysfunction-Associated Fatty Liver Disease in Mice through Regulating Gut Microbiota and Liver Endoplasmic Reticulum Stress
por: Hu, Wenjing, et al.
Publicado: (2023)

Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics
por: He, Xuyun, et al.
Publicado: (2016)

Characteristics of Gut Microbiota in Children With Biliary Atresia After Liver Transplantation
por: Song, Wei, et al.
Publicado: (2021)

Intestinal microbiota in the treatment of metabolically associated fatty liver disease
por: Wang, Ji-Shuai, et al.
Publicado: (2022)

Metabolic-Associated Fatty Liver Disease (MAFLD), Diabetes, and Cardiovascular Disease: Associations with Fructose Metabolism and Gut Microbiota
por: Drożdż, Karolina, et al.
Publicado: (2021)

Gut microbiota and metabolic syndrome
por: Wang, Peng-Xu, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease, diet and gut microbiota
por: Finelli, Carmine, et al.
Publicado: (2014)

Retraction: Nonalcoholic fatty liver disease, diet and gut microbiota
por: Finelli, Carmine, et al.
Publicado: (2017)

Gut Microbiota in Adolescents and the Association with Fatty Liver: the EPOCH Study
por: Stanislawski, Maggie A., et al.
Publicado: (2018)

Gut Microbiota and Risk of Persistent Nonalcoholic Fatty Liver Diseases
por: Kim, Han-Na, et al.
Publicado: (2019)

Fatty Liver Disease and Gut Microbiota: A Comprehensive Update
por: Campo, Lyna, et al.
Publicado: (2018)

Metagenome of Gut Microbiota of Children With Nonalcoholic Fatty Liver Disease
por: Zhao, Yuzhen, et al.
Publicado: (2019)

Food and Gut Microbiota-Derived Metabolites in Nonalcoholic Fatty Liver Disease
por: Jeong, Min Kyo, et al.
Publicado: (2022)

Characteristics of mucosa-associated gut microbiota during treatment in Crohn’s disease
por: He, Cong, et al.
Publicado: (2019)

The role of gut microbiota in liver regeneration
por: Xu, Zhe, et al.
Publicado: (2022)

Associations among Dietary Omega-3 Polyunsaturated Fatty Acids, the Gut Microbiota, and Intestinal Immunity
por: Fu, Yawei, et al.
Publicado: (2021)

Astaxanthin Prevents Alcoholic Fatty Liver Disease by Modulating Mouse Gut Microbiota
por: Liu, Huilin, et al.
Publicado: (2018)

Dietary fatty acids in gut health: Absorption, metabolism and function
por: Xu, E., et al.
Publicado: (2021)

Mechanisms linking bariatric surgery to adipose tissue, glucose metabolism, fatty liver disease and gut microbiota
por: Latteri, Saverio, et al.
Publicado: (2023)

Vitamin D alleviates non-alcoholic fatty liver disease via restoring gut microbiota and metabolism
por: Zhang, Xiao-Lei, et al.
Publicado: (2023)

Current insights into the interplay between gut microbiota-derived metabolites and metabolic-associated fatty liver disease
por: Dongoran, Rachmad Anres, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0t9fuabiqnsevh5n5rbjpjn3f3